T1	Outcomes 10 37	pharmacokinetic interaction
T2	Outcomes 272 307	pharmacokinetics of the CYP3A probe
T3	Outcomes 740 780	clearance and peak and systemic exposure
T4	Outcomes 898 928	pharmacokinetics of midazolam.
T5	Outcomes 1186 1230	disposition of the CYP3A substrate midazolam
